WELCOME

Biosight is a Tennessee-based Limited Liability Corporation, which was incorporated in 2018 and operates as a clinical research organization (CRO) with specific expertise in advanced imaging acquisition strategies and analysis algorithms. The company mission focuses on improving health outcomes by enhancing clinical trial efficiency through the incorporation of sensitive imaging markers of tissue physiology, which can be used to (i) refine enrollment criteria for more informed patient stratification and (ii) expand clinically meaningful endpoints to increase the likelihood of trial success.

Contact

SERVICES

Advising on clinical trial design and biomarker selection

Implementing new and common imaging methodologies in research studies and trials

Assisting with government grant proposals and offering training workshops

More Info

PROJECTS

Using brain oxygen extraction fraction as a new diagnostic screening tool to predict stroke recurrence

Optimizing lymphatic fluid mobilization therapies in patients undergoing cancer therapies

Using molecular tissue signatures to identify phenotypic manifestations of fat disorders

More Info

CLIENTS

National Institutes of Health funded academic research teams across major United States medical centers and universities

Pharmaceutical industries running early-stage clinical trials

Healthcare technology companies seeking to validate new therapeutic tools

More Info

Discovering

New Treatments

Exploring the realm of clinical trials to uncover innovative solutions for patients battling neurodegenerative disorders is our passion at Biosight Consulting, LLC. We are dedicated to advancing medical research and improving healthcare outcomes through our commitment to excellence and patient-centric approach. Our team of experts works tirelessly to drive progress and bring hope to those in need. Join us in our mission to make a difference in the lives of individuals worldwide.

Learn More

CONTACT US

info@biosightllc.com

Tel: 615.939.2869

contact